Cargando…

Ventilator-associated pneumonia in patients undergoing major heart surgery: an incidence study in Europe

INTRODUCTION: Patients undergoing major heart surgery (MHS) represent a special subpopulation at risk for nosocomial infections. Postoperative infection is the main non-cardiac complication after MHS and has been clearly related to increased morbidity, use of hospital resources and mortality. Our ai...

Descripción completa

Detalles Bibliográficos
Autores principales: Hortal, Javier, Muñoz, Patricia, Cuerpo, Gregorio, Litvan, Hector, Rosseel, Peter M, Bouza, Emilio
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2717444/
https://www.ncbi.nlm.nih.gov/pubmed/19463176
http://dx.doi.org/10.1186/cc7896
_version_ 1782169899961942016
author Hortal, Javier
Muñoz, Patricia
Cuerpo, Gregorio
Litvan, Hector
Rosseel, Peter M
Bouza, Emilio
author_facet Hortal, Javier
Muñoz, Patricia
Cuerpo, Gregorio
Litvan, Hector
Rosseel, Peter M
Bouza, Emilio
author_sort Hortal, Javier
collection PubMed
description INTRODUCTION: Patients undergoing major heart surgery (MHS) represent a special subpopulation at risk for nosocomial infections. Postoperative infection is the main non-cardiac complication after MHS and has been clearly related to increased morbidity, use of hospital resources and mortality. Our aim was to determine the incidence, aetiology, risk factors and outcome of ventilator-associated pneumonia (VAP) in patients who have undergone MHS in Europe. METHODS: Our study was a prospective study of patients undergoing MHS in Europe who developed suspicion of VAP. During a one-month period, participating units submitted a protocol of all patients admitted to their units who had undergone MHS. RESULTS: Overall, 25 hospitals in eight different European countries participated in the study. The number of patients intervened for MHS was 986. Fifteen patients were excluded because of protocol violations. One or more nosocomial infections were detected in 43 (4.4%) patients. VAP was the most frequent nosocomial infection (2.1%; 13.9 episodes per 1000 days of mechanical ventilation). The microorganisms responsible for VAP in this study were: Enterobacteriaceae (45%), Pseudomonas aeruginosa (20%), methicillin-resistant Staphylococcus aureus (10%) and a range of other microorganisms. We identified the following significant independent risk factors for VAP: ascending aorta surgery (odds ratio (OR) = 6.22; 95% confidence interval (CI) = 1.69 to 22.89), number of blood units transfused (OR = 1.08 per unit transfused; 95% CI = 1.04 to 1.13) and need for re-intervention (OR = 6.65; 95% CI = 2.10 to 21.01). The median length of stay in the intensive care unit was significantly longer (P < 0.001) in patients with VAP than in patients without VAP (23 days versus 2 days). Death was significantly more frequent (P < 0.001) in patients with VAP (35% versus 2.3%). CONCLUSIONS: Patients undergoing aortic surgery and those with complicated post-intervention courses, requiring multiple transfusions or re-intervention, constitute a high-risk group probably requiring more active preventive measures.
format Text
id pubmed-2717444
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-27174442009-07-29 Ventilator-associated pneumonia in patients undergoing major heart surgery: an incidence study in Europe Hortal, Javier Muñoz, Patricia Cuerpo, Gregorio Litvan, Hector Rosseel, Peter M Bouza, Emilio Crit Care Research INTRODUCTION: Patients undergoing major heart surgery (MHS) represent a special subpopulation at risk for nosocomial infections. Postoperative infection is the main non-cardiac complication after MHS and has been clearly related to increased morbidity, use of hospital resources and mortality. Our aim was to determine the incidence, aetiology, risk factors and outcome of ventilator-associated pneumonia (VAP) in patients who have undergone MHS in Europe. METHODS: Our study was a prospective study of patients undergoing MHS in Europe who developed suspicion of VAP. During a one-month period, participating units submitted a protocol of all patients admitted to their units who had undergone MHS. RESULTS: Overall, 25 hospitals in eight different European countries participated in the study. The number of patients intervened for MHS was 986. Fifteen patients were excluded because of protocol violations. One or more nosocomial infections were detected in 43 (4.4%) patients. VAP was the most frequent nosocomial infection (2.1%; 13.9 episodes per 1000 days of mechanical ventilation). The microorganisms responsible for VAP in this study were: Enterobacteriaceae (45%), Pseudomonas aeruginosa (20%), methicillin-resistant Staphylococcus aureus (10%) and a range of other microorganisms. We identified the following significant independent risk factors for VAP: ascending aorta surgery (odds ratio (OR) = 6.22; 95% confidence interval (CI) = 1.69 to 22.89), number of blood units transfused (OR = 1.08 per unit transfused; 95% CI = 1.04 to 1.13) and need for re-intervention (OR = 6.65; 95% CI = 2.10 to 21.01). The median length of stay in the intensive care unit was significantly longer (P < 0.001) in patients with VAP than in patients without VAP (23 days versus 2 days). Death was significantly more frequent (P < 0.001) in patients with VAP (35% versus 2.3%). CONCLUSIONS: Patients undergoing aortic surgery and those with complicated post-intervention courses, requiring multiple transfusions or re-intervention, constitute a high-risk group probably requiring more active preventive measures. BioMed Central 2009 2009-05-22 /pmc/articles/PMC2717444/ /pubmed/19463176 http://dx.doi.org/10.1186/cc7896 Text en Copyright © 2009 Hortal et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an open access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Hortal, Javier
Muñoz, Patricia
Cuerpo, Gregorio
Litvan, Hector
Rosseel, Peter M
Bouza, Emilio
Ventilator-associated pneumonia in patients undergoing major heart surgery: an incidence study in Europe
title Ventilator-associated pneumonia in patients undergoing major heart surgery: an incidence study in Europe
title_full Ventilator-associated pneumonia in patients undergoing major heart surgery: an incidence study in Europe
title_fullStr Ventilator-associated pneumonia in patients undergoing major heart surgery: an incidence study in Europe
title_full_unstemmed Ventilator-associated pneumonia in patients undergoing major heart surgery: an incidence study in Europe
title_short Ventilator-associated pneumonia in patients undergoing major heart surgery: an incidence study in Europe
title_sort ventilator-associated pneumonia in patients undergoing major heart surgery: an incidence study in europe
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2717444/
https://www.ncbi.nlm.nih.gov/pubmed/19463176
http://dx.doi.org/10.1186/cc7896
work_keys_str_mv AT hortaljavier ventilatorassociatedpneumoniainpatientsundergoingmajorheartsurgeryanincidencestudyineurope
AT munozpatricia ventilatorassociatedpneumoniainpatientsundergoingmajorheartsurgeryanincidencestudyineurope
AT cuerpogregorio ventilatorassociatedpneumoniainpatientsundergoingmajorheartsurgeryanincidencestudyineurope
AT litvanhector ventilatorassociatedpneumoniainpatientsundergoingmajorheartsurgeryanincidencestudyineurope
AT rosseelpeterm ventilatorassociatedpneumoniainpatientsundergoingmajorheartsurgeryanincidencestudyineurope
AT bouzaemilio ventilatorassociatedpneumoniainpatientsundergoingmajorheartsurgeryanincidencestudyineurope